The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models
Abstract
The regular use of cannabis during adolescence is of particular concern because use by this age group seems to be associated with an increased likelihood of deleterious consequences, as reported by several epidemiologic studies. However, despite their unquestionable value, epidemiologic data are inconclusive. Modeling the adolescent phase in animals appears to be a useful approach to investigate the impact of cannabis use on the adolescent brain. In these models, adolescent cannabinoid exposure has been reported to cause long-term impairment in specific components of learning and memory and to have differential effects on anxiety, social behavior, and depressive-like signs. These findings suggest that it may represent, per se or in association with other hits, a risk factor for developing psychotic-like symptoms in adulthood. The neurobiological bases of this association include the induction of alterations in the maturational events of the endocannabinoid system occurring in the adolescent brain. Alterations in the endocannabinoid system may profoundly dysregulate developmental processes in some neurotransmitter systems, such as gamma-aminobutyric acid and glutamate, mainly in the cortex. The resulting picture strongly resembles the one present in schizophrenic patients, highlighting the translational value of this experimental approach.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of the detrimental effects of cannabis on behavior seem more pronounced in females in both animals 19 and humans, 15 although this finding remains controversial.”
From Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood (2019) · cites this paper as [19]
In the citing paper
“Additional studies further demonstrate the neurobiological and the pathophysiological depressionlike behavior of adolescent rats when exposed to cannabinoids.19”
From Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood (2019) · cites this paper as [19]
Citations
Cites
Neuronal Oscillations in Cortical Networks
Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576
Dynamic mapping of human cortical development during childhood through early adulthood
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., Nugent, T. F., Herman, D. H., Clasen, L. S., Toga, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402680101 · Cited by 5,604 · cited 1×
“N: 0006-3223 SEE COMMENTA more primitive brain regions and later in phylogenetically newer regions, with the most anterior regions of the frontal and temporal lobes being the last to attain adult organization (6,7,9).”
BackgroundBrain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120
Neurophysiological and Computational Principles of Cortical Rhythms in Cognition
Wang, X.-J. (2010) · Physiological Reviews · doi:10.1152/physrev.00035.2008 · Cited by 1,939
In vivo evidence for post-adolescent brain maturation in frontal and striatal regions
Sowell, E. R., Thompson, P. M., Holmes, C. J., Jernigan, T. L., & Toga, A. W. (1999) · Nature Neuroscience · doi:10.1038/13154 · Cited by 1,439
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Morphometric study of human cerebral cortex development
Huttenlocher, P. R. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90031-i · Cited by 1,239
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Mei, L., & Xiong, W.-C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2392 · Cited by 1,030
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Flagged first, then by citations
1 of the 98 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., Marmorstein, N., Cipriani, A., Dendukuri, N., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.4500 · Cited by 914
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development
Meyer, H. C., Lee, F. S., & Gee, D. G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.143 · Cited by 238
Hazekamp, A. (2018) · Medical Cannabis and Cannabinoids · doi:10.1159/000489287 · Cited by 203
Association of Cannabis Use During Adolescence With Neurodevelopment
Albaugh, M. D., Ottino-Gonzalez, J., Sidwell, A., Lepage, C., Juliano, A., Owens, M. M., Chaarani, B., Spechler, P., Fontaine, N., Rioux, P., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1258 · Cited by 176
Dow-Edwards, D. L., MacMaster, F. P., Peterson, B. S., Niesink, R. J. M., Andersen, S. L., & Braams, B. R. (2019) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2019.106834 · Cited by 160
Haspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 148
Miller, M. L., Chadwick, B., Dickstein, D. L., Purushothaman, I., Egervari, G., Rahman, T., Tessereau, C., Hof, P. R., Roussos, P., Shen, L., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0243-x · Cited by 134
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior
Szutorisz, H., & Hurd, Y. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.011 · Cited by 131
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
Poleg, S., Golubchik, P., Offen, D., & Weizman, A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.030 · Cited by 124
Castellanos-Ryan, N., Pingault, J.-B., Parent, S., Vitaro, F., Tremblay, R. E., & Séguin, J. R. (2017) · Development and Psychopathology · doi:10.1017/s0954579416001280 · Cited by 111
Endocannabinoid Signaling in the Control of Social Behavior
Don, W., Allsop, S. A., Tye, K. M., & Piomelli, D. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.005 · Cited by 120
Mokrysz, C., Freeman, T. P., Korkki, S. M., Griffiths, K., & Curran, H. V. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.225 · Cited by 107
Febo, M., Blum, K., Badgaiyan, R. D., Pérez, P. D., Colón-Pérez, L. M., Thanos, P. K., Ferris, C. F., Kulkarni, P. P., Giordano, J., Baron, D. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174774 · Cited by 107
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Rohleder, C., Müller, J. K., Lange, B., & Leweke, F. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00422 · Cited by 94
Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male Mice
Torrens, A., Vozella, V., Huff, H., McNeil, B., Ahmed, F., Ghidini, A., Mahler, S. V., Huestis, M. A., Das, A., & Piomelli, D. (2020) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265892 · Cited by 88
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
D’Souza, D. C., Forti, M. D., Ganesh, S., George, T. P., Hall, W., Hjorthøj, C. R., Howes, O. D., Keshavan, M. S., Murray, R. M., Nguyen, T. B., et al. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2038797 · Cited by 91
Blest‐Hopley, G., Colizzi, M., Giampietro, V., & Bhattacharyya, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00859 · Cited by 92
Cannabis and development of dual diagnoses: A literature review
Hanna, R. C., Perez, J. M., & Ghose, S. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1213273 · Cited by 93
de Salas-Quiroga, A., García-Rincón, D., Gómez-Domínguez, D., Valero, M., Simón-Sánchez, S., Paraíso‐Luna, J., Aguareles, J., Pujadas, M., Muguruza, C., Callado, L. F., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0621-3 · Cited by 85
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice
Busquets-García, A., Gómez, E. S., Redon, B., Mackenbach, Y., Vallée, M., Chaouloff, F., Varilh, M., Ferreira, G., Piazza, P.-V., & Marsicano, G. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.4 · Cited by 78
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Ibarra‐Lecue, I., Mollinedo-Gajate, I., Meana, J. J., Callado, L. F., Dı́ez-Alarcia, R., & Urigüen, L. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0076-y · Cited by 77
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
Dı́ez-Alarcia, R., Ibarra‐Lecue, I., López‐Cardona, A. P., Meana, J. J., Gutiérrez‐Adán, A., Callado, L. F., Agirregoitia, E., & Urigüen, L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00415 · Cited by 73
The Psychiatric Consequences of Cannabinoids
Aquino, J. P. D., Sherif, M. A., Radhakrishnan, R., Cahill, J. D., Ranganathan, M., & D’Souza, D. C. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.03.013 · Cited by 70
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthoodPreprint
Alteba, S., Korem, N., & Akirav, I. (2016) · Learning & Memory · doi:10.1101/lm.041608.116 · Cited by 63
Advancing the science on cannabis concentrates and behavioural health
Bidwell, L. C., Martin‐Willett, R., & Karoly, H. C. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13281 · Cited by 60
The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
Sorkhou, M., Bedder, R. H., & George, T. P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.630247 · Cited by 61
Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders
Krebs, M., Kébir, O., & Jay, T. M. (2019) · European Journal of Pain · doi:10.1002/ejp.1377 · Cited by 64
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
D’Souza, D. C., Radhakrishnan, R., Naganawa, M., Ganesh, S., Nabulsi, N., Najafzadeh, S., Ropchan, J., Ranganathan, M., Cortes-Briones, J., Huang, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00891-4 · Cited by 55
Ruiz, C. M., Torrens, A., Lallai, V., Castillo, E., Manca, L., Martinez, M. X., Justeson, D. N., Fowler, C. D., Piomelli, D., & Mahler, S. V. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05976-8 · Cited by 56
Jouroukhin, Y., Zhu, X., Shevelkin, A. V., Hasegawa, Y., Abazyan, B. N., Saito, A., Pevsner, J., Kamiya, A., & Pletnikov, M. V. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.07.024 · Cited by 55
Weinberger, A. H., Zhu, J., Lee, J., Anastasiou, E., Copeland, J., & Goodwin, R. D. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107894 · Cited by 60
Altıntaş, M., İnanç, L., Oruç, G. A., Arpacıoğlu, S., & Güleç, H. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s107622 · Cited by 50
Exploring Cannabis and Alcohol Co-Use in Adolescents: A Narrative Review of the Evidence
Karoly, H. C., Ross, J. M., Ellingson, J. M., & Feldstein Ewing, S. W. (2020) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1660020 · Cited by 46
Scherma, M., Qvist, J. S., Asok, A., Huang, S. C., Masia, P., Deidda, M. L., Wei, Y. B., Soni, R. K., Fratta, W., Fadda, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920866117 · Cited by 47
Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
Agarwal, R., Burke, S. L., & Maddux, M. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2259-4 · Cited by 46
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
Rodrigues, R. S., Lourenço, D. M., Paulo, S. L., Mateus, J. M., Ferreira, M. F., Mouro, F. M., Moreira, J. B., Ribeiro, F. F., Sebastião, A. M., & Xapelli, S. (2019) · Molecules · doi:10.3390/molecules24071350 · Cited by 47
Stringfield, S. J., & Torregrossa, M. M. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05684-9 · Cited by 41
Lichenstein, S. D., Musselman, S. C., Shaw, D. S., Sitnick, S. L., & Forbes, E. E. (2017) · Addiction · doi:10.1111/add.13882 · Cited by 45
The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity
Struik, D., Sanna, F., & Fattore, L. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00249 · Cited by 44
Tirado-Muñoz, J., López-Rodríguez, A. B., Fonseca, F., Farré, M., Torrens, M., & Viveros, M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100841 · Cited by 45
Borsoï, M., Manduca, A., Bara, A., Lassalle, O., Pélissier‐Alicot, A., & Manzoni, O. J. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00023 · Cited by 39
Corongiu, S., Dessì, C., & Cadoni, C. (2020) · Addiction Biology · doi:10.1111/adb.12721 · Cited by 36
Leishman, E., Murphy, M., Mackie, K., & Bradshaw, H. B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.02.001 · Cited by 42
Lee, H.-L., Jung, K.-M., Fotio, Y., Squire, E., Palese, F., Lin, L., Torrens, A., Ahmed, F., Mabou Tagne, A., Ramirez, J., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.04.017 · Cited by 38
Uso da Cannabis medicinal e autismo
Lima, M. C. M., Valênça, M. M., Machado, C. E., Pereira, M. E. D. M., & Brant, P. K. (2020) · Jornal Memorial da Medicina · doi:10.37085/jmmv2.n1.2020.pp.5-14 · Cited by 37
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence
Rodrigues, R. J., Marques, J. M., & Köfalvi, A. (2024) · Cells · doi:10.3390/cells13221875 · Cited by 43
Effects of Marijuana Use on Brain Structure and Function
Brumback, T., Castro, N., Jacobus, J., & Tapert, S. F. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.004 · Cited by 38
New vistas on cannabis use disorder
Melis, M., Frau, R., Kalivas, P. W., Spencer, S. M., Chioma, V. C., Zamberletti, E., Rubino, T., & Parolaro, D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.033 · Cited by 38
Self-citationPrini, P., Penna, F., Sciuccati, E., Alberio, T., & Rubino, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102094 · Cited by 37
Self-citationAdolescent cannabinoid exposure effects on natural reward seeking and learning in rats
Schoch, H., Huerta, M. Y., Ruiz, C. M., Farrell, M. R., Jung, K., Huang, J. J., Campbell, R. R., Piomelli, D., & Mahler, S. V. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4749-8 · Cited by 36
Saravia, R., Ten-Blanco, M., Julià‐Hernández, M., Gagliano, H., Andero, R., Armario, A., Maldonado, R. J., & Berrendero, F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.016 · Cited by 38
Poulia, N., Delis, F., Brakatselos, C., Lekkas, P., Kokras, N., Dalla, C., & Antoniou, K. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14598 · Cited by 35
Blest‐Hopley, G., Giampietro, V., & Bhattacharyya, S. (2020) · Brain Sciences · doi:10.3390/brainsci10020102 · Cited by 38
Gabaglio, M., Zamberletti, E., Manenti, C., Parolaro, D., & Rubino, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168899 · Cited by 34
Self-citationEllingson, J. M., Ross, J. M., Winiger, E. A., Stallings, M. C., Corley, R. P., Friedman, N. P., Hewitt, J. K., Tapert, S. F., Brown, S. A., Wall, T. L., et al. (2020) · Addiction · doi:10.1111/add.15207 · Cited by 32
Adolescent alcohol and cannabis use in Iceland 1995–2015
Arnarsson, Á. M., Kristofersson, G. K., & Bjarnason, Þ. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12587 · Cited by 33
Emerging Mechanisms Underlying Dynamics of GABAergic Synapses
Maffei, A., Charrier, C., Caiati, M. D., Barberis, A., Mahadevan, V., Woodin, M. A., & Tyagarajan, S. K. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1824-17.2017 · Cited by 35
Cuccurazzu, B., Zamberletti, E., Nazzaro, C., Prini, P., Trusel, M., Grilli, M., Parolaro, D., Tonini, R., & Rubino, T. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy057 · Cited by 31
Self-citationMouro, F. M., Köfalvi, A., André, L., Baqi, Y., Müller, C. E., Ribeiro, J. A., & Sebastião, A. M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.003 · Cited by 30
Hellemans, K. G. C., Wilcox, J., Nino, J. N., Young, M. M., & McQuaid, R. J. (2019) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000059 · Cited by 31
Neurobiological mechanisms underlying cannabis-induced memory impairment
Prini, P., Zamberletti, E., Manenti, C., Gabaglio, M., Parolaro, D., & Rubino, T. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.02.002 · Cited by 32
Self-citationLecca, S., Luchicchi, A., Scherma, M., Fadda, P., Muntoni, A. L., & Pistis, M. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00202 · Cited by 33
Early 5‐HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse
Berthoux, C., Hamieh, A. M., Rogliardo, A., Doucet, E. L., Coudert, C., Ango, F., Grychowska, K., Chaumont‐Dubel, S., Zajdel, P., Maldonado, R. J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910605 · Cited by 32
Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition
Zamberletti, E., & Rubino, T. (2022) · Molecules · doi:10.3390/molecules27041411 · Cited by 30
Self-citationAssociations between adolescent cannabis use and brain structure in psychosis
Abush, H., Ghose, S., Enkevort, E. A. V., Clementz, B. A., Pearlson, G. D., Sweeney, J. A., Keshavan, M. S., Tamminga, C. A., & Ivleva, E. I. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.03.008 · Cited by 27
Felice, M. D., Renard, J., Hudson, R., Szkudlarek, H. J., Pereira, B. J. G., Schmid, S., Rushlow, W. J., & Laviolette, S. R. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1050-20.2020 · Cited by 26
Lawn, W., Fernandez‐Vinson, N., Mokrysz, C., Hogg, G., Lees, R., Trinci, K., Petrilli, K., Borissova, A., Ofori, S., Waters, S., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06143-3 · Cited by 30
Torrens, A., Roy, P., Lin, L., Vu, C., Grimes, D., Inshishian, V. C., Montesinos, J. S., Ahmed, F., Mahler, S. V., Huestis, M. A., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0205 · Cited by 26
Frontera, J. L., Pini, V. M. G., Messore, F., & Brusco, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.018 · Cited by 24
Mokrysz, C., Shaban, N. D. C., Freeman, T. P., Lawn, W., Pope, R. A., Hindocha, C., Freeman, A. M., Wall, M. B., Bloomfield, M., Morgan, C. J. A., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720001038 · Cited by 24
Orihuel, J., Capellán, R., Roura-Martínez, D., Ucha, M., Ambrosio, E., & Higuera-Matas, A. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab058 · Cited by 23
Kwan, L. Y., Eaton, D. L., Andersen, S. L., Dow-Edwards, D. L., Levin, E. D., Talpos, J. C., Vorhees, C. V., & Li, A. A. (2020) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2020.106916 · Cited by 25
Alteba, S., Portugalov, A., Hillard, C. J., & Akirav, I. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.12.022 · Cited by 24
Iemolo, A., Montilla‐Perez, P., Nguyen, J. D., Risbrough, V. B., Taffe, M. A., & Telese, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108495 · Cited by 18
Cannabinoid CB1 receptor-sensitive neurodevelopmental processes and trajectories
Tseng, K. Y., & Molla, H. M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03057-2 · Cited by 20
Torrens, A., Ruiz, C., Martinez, M. X., Tagne, A. M., Roy, P., Grimes, D., Ahmed, F., Lallai, V., Inshishian, V., Bautista, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106600 · Cited by 14
Marijuana and Madness: Associations Between Cannabinoids and Psychosis
Ranganathan, M., Skosnik, P. D., & D’Souza, D. C. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.007 · Cited by 18
Fatty Acid Amide Hydrolase: An Integrative Clinical Perspective
Santoso, A. D., & Ridder, D. J. M. K. D. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0237 · Cited by 19
Hartberg, C. B., Lange, E. H., Lagerberg, T. V., Haukvik, U. K., Andreassen, O. A., Melle, I. S., & Agartz, I. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.019 · Cited by 18
Beggiato, S., Ieraci, A., Zuccarini, M., Iorio, P. D., Schwarcz, R. M., & Ferraro, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.996406 · Cited by 17
Multiple Cerebral Infarcts in a Young Patient Associated With Marijuana Use
Volpon, L. C., Sousa, C. L. M. D. M., Moreira, S. K. K., Teixeira, S. R., & Carlotti, A. P. D. C. P. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000326 · Cited by 17
Dunn, A. L., Michie, P. T., Hodgson, D. M., & Harms, L. R. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.028 · Cited by 15
Mun, C. J., Dishion, T. J., Tein, J., & Otten, R. (2017) · Development and Psychopathology · doi:10.1017/s0954579417001742 · Cited by 17
Zamberletti, E., & Rubino, T. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.06.013 · Cited by 17
Self-citationCinquina, V., Keimpema, E., Pollak, D. D., & Harkany, T. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13320 · Cited by 16
Freels, T. G., Westbrook, S. R., Zamberletti, E., Kuyat, J. R., Wright, H. R., Malena, A. N., Melville, M. W., Brown, A. M., Glodosky, N. C., Ginder, D. E., et al. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0014 · Cited by 22
Self-citationThe cannabidiol conundrum: potential benefits and risks of cannabidiol products for children
Singer, L., Tokish, H., Park, F., Campisi, C., & Milanaik, R. L. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000861 · Cited by 16
Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear
Bisby, M. A., Richardson, R., & Baker, K. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109834 · Cited by 15
Camchong, J., Collins, P. F., Becker, M. P., Lim, K. O., & Luciana, M. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00514 · Cited by 15
Representation-mediated Aversion as a Model to Study Psychotic-like States in Mice
Busquets-García, A., Gómez, E. S., Ferreira, G., & Marsicano, G. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2358 · Cited by 14
Disrupting the endocannabinoid system in early adolescence negatively impacts sociability
Cossio, D. M., Stadler, H., Michas, Z., Johnston, C. J., & López, H. H. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172832 · Cited by 13
Macías-Triana, L., Romero-Cordero, K., Tatum-Kuri, A., Vera-Barrón, A., Millán‐Aldaco, D., Arankowsky‐Sandoval, G., Piomelli, D., & Murillo‐Rodríguez, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172911 · Cited by 13
Flores, Á., Maldonado, R. J., & Berrendero, F. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05416-8 · Cited by 13
Izquierdo-Luengo, C., Ten-Blanco, M., Ponce-Renilla, M., Perezzan, R., Pereda-Pérez, I., & Berrendero, F. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02469-4 · Cited by 13
Sabran‐Cohen, T., Bright, U., Zer‐Aviv, T. M., & Akirav, I. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15425 · Cited by 14
Blum, K., Marcelo, F., Dushaj, K., Fried, L., & Badgaiyan, R. D. (2016) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000129 · Cited by 13
Cognitive risk factors for alcohol and substance addictions
Ryan, N. C., & Conrod, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00007-1 · Cited by 13
Cannabis et neurodéveloppement
Krebs, M., Demars, F., Frajerman, A., Kébir, O., & Jay, T. M. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2020.04.002 · Cited by 12
Metadata
- Authors
- Rubino, T., & Parolaro, D.
- Affiliations
- University of Insubria (IT)
- Corresponding author
- Rubino, Tiziana
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 79
- Issue
- 7
- Pages
- 578-585
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1068045543
- Cited by
- 183
- References
- 98
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 11 · 2023: 8 · 2022: 16 · 2021: 17 · 2020: 29 · 2019: 24 · 2018: 15 · 2017: 22 · 2016: 15
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Italian Department of Drug Policies (project ADOCANNABIS to DP) (2008.2203)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- adolescent cannabis use, adolescent brain development, learning and memory impairment, anxiety, social behavior, depression-like behavior, psychotic-like symptoms, schizophrenia risk, GABA, glutamate, cortical development
- MeSH terms
- Adolescent, Animals, Brain, Cannabinoids, Marijuana Abuse, Cognition, Disease Models, Animal, gamma-Aminobutyric Acid, Humans, Learning, Memory, Psychoses, Substance-Induced, Mice, Rats, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review